Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting-Hsing Chao

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
International Heart Journal|March 18, 2021
Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary InterventionCheng-Han Lee, Mu-Shiang Huang, Ting-Hsing Chao, et al.
Acta Cardiologica Sinica|October 2, 2018
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk PatientsYi-Heng Li, Ting-Hsing Chao, Ping-Yen Liu, et al.
International Heart Journal|April 16, 2009
A novel inhibitory effect of Antrodia camphorata extract on vascular smooth muscle cell migration and neointima formation in miceYi-Heng Li, Hsing-Chun Chung, Shu-Lin Liu, et al.
International Heart Journal|December 28, 2007
Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndromeYi-Heng Li, Hui-Ling Wu, Yea-Huei Kao Yang, et al.
Clinical Science (London, England : 1979)|March 3, 2005
Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertensionWei-Chuan Tsai, Yi-Heng Li, Yao-Yi Huang, et al.
Clinical Cardiology|August 10, 2004
Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventionsTing-Hsing Chao, Yi-Heng Li, Wei-Chuan Tsai, et al.
Oncotarget|January 4, 2018
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9I-Chih Chen, Wei-Kung Tseng, Yi-Heng Li, et al.
Acta Cardiologica Sinica|March 13, 2023
Management of Restenosis after Stenting in Left Main Coronary Artery DiseaseChen-Wei Huang, Mu-Shiang Huang, Pei-Fang Su, et al.
Plos One|August 21, 2025
Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysisHsien-Yuan Chang, Hui-Wen Lin, Po-Wei Chen, et al.
Clinical Cardiology|May 3, 2025
Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery DiseasePo-Hsueh Su, Ya-Lin Huang, Po-Wei Chen, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
International Heart Journal|March 18, 2021
Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary InterventionCheng-Han Lee, Mu-Shiang Huang, Ting-Hsing Chao, et al.
Acta Cardiologica Sinica|October 2, 2018
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk PatientsYi-Heng Li, Ting-Hsing Chao, Ping-Yen Liu, et al.
International Heart Journal|April 16, 2009
A novel inhibitory effect of Antrodia camphorata extract on vascular smooth muscle cell migration and neointima formation in miceYi-Heng Li, Hsing-Chun Chung, Shu-Lin Liu, et al.
International Heart Journal|December 28, 2007
Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndromeYi-Heng Li, Hui-Ling Wu, Yea-Huei Kao Yang, et al.
Clinical Science (London, England : 1979)|March 3, 2005
Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertensionWei-Chuan Tsai, Yi-Heng Li, Yao-Yi Huang, et al.
Clinical Cardiology|August 10, 2004
Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventionsTing-Hsing Chao, Yi-Heng Li, Wei-Chuan Tsai, et al.
Oncotarget|January 4, 2018
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9I-Chih Chen, Wei-Kung Tseng, Yi-Heng Li, et al.
Acta Cardiologica Sinica|March 13, 2023
Management of Restenosis after Stenting in Left Main Coronary Artery DiseaseChen-Wei Huang, Mu-Shiang Huang, Pei-Fang Su, et al.
Plos One|August 21, 2025
Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysisHsien-Yuan Chang, Hui-Wen Lin, Po-Wei Chen, et al.
Clinical Cardiology|May 3, 2025
Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery DiseasePo-Hsueh Su, Ya-Lin Huang, Po-Wei Chen, et al.
Pageof 11